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ABSTRACT: Polymeric nanoparticles are widely investigated to enhance the selectivity of 
therapeutics to targeted sites, as well as to increase circulation lifetime and water solubility of 
poorly soluble drugs. In contrast to the encapsulation of the cargo into the nanostructures, the 
conjugation directly to the polymer backbone allows better control on the loading and selective 
 2 
triggered release. In this work we report a simple procedure to create biodegradable 
polycarbonate graft copolymer nanoparticles via a ring opening polymerization and subsequent 
post-polymerization modification strategies. The polymer, designed with both pH responsive 
acetal linkages and a norbornene group, allows for highly efficient post-polymerization 
modifications through a range of chemistries to conjugate imaging agents and solubilizing arms 
to direct self-assembly. To demonstrate the potential of this approach, polycarbonate-based 
nanoparticles were tested for biocompatibility and ability to be internalized in A549 and IMR-90 
cell lines. 
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INTRODUCTION  
In the past three decades, polymeric nanoparticles have emerged as a promising tool for targeted 
delivery. Their ability to increase the half life of cytotoxic drugs in the blood, impart aqueous 
solubility, minimize recognition and uptake by reticuloendothelial systems, and enhance 
structural stability has made them attractive to study as potential delivery vehicles.
1-5
 In 
particular, polymeric conjugates, where the cargo is covalently linked to the polymer backbone, 
as opposed to encapsulated in the polymeric core, are especially attractive, as they allow 
predictable drug loading, enhanced stability at normal physiological conditions and afford a high 
level of control over the selective triggering of the release event which leads to enhanced 
therapeutic efficacy and minimizes potential side effects.
6
 Furthermore, if the conjugated cargo 
can be released in response to a specific intracellular trigger (i.e. changes in pH, temperature, or 
the presence of redox linkers etc.), the delivery can be selectively directed to the targeted site.
7-9
 
Among these, many passive targeting strategies hinge on the fact that the extracellular pH of 
both primary and metastasized tumors is lower than the pH of normal tissues.
10-14
 pH sensitive 
micelles can be triggered to release therapeutic agents in endosomes or lysosomes by hydrolysis 
or dissociation after uptake by cells via the endocytic pathway,
6, 15-17
 as the pH experienced by 
the micelles once they enter cells via endocytosis can drop as low as 5.0-6.0 in endosomes and 
4.0-5.0 in lysosomes.
18, 19
 The fate of the endocytosed polymeric micelles typically relies on the 
efficiency of lysosomal escape, which has to be sufficiently fast to avoid degradation by 
lysosomal enzymes but prolonged enough to ensure particle disassembly.
20
  
A number of chemistries have been utilized to produce micelles in which the release of the 
cargo is triggered by a drop in pH.
21
 Hydrazone,
22-26
 orthoester,
27-29
 vinyl ether,
30, 31
 cys-
acotinyl
32, 33
 and acetal
34-38
 linkages have each been shown to release the conjugated drug much 
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faster at a pH interval between 5.0 and 6.0, compared to physiological pH 7.4. Among them, 
polyacetals undergo a pH-dependent degradation but also produce biocompatible degradation 
products, such as alcohols and aldehydes. Many of the approaches used to prepare such 
polymeric conjugates however, rely on multi-step syntheses of amphiphilic di-block 
(hydrophilic-hydrophobic) or tri-block (hydrophilic-hydrophobic-hydrophilic) copolymers,
4, 14, 
39-41
 or composite architectures, such as dendrimeric/hyperbranched structures,
42-44
 that have 
significant non-degradable fragments. Further innovative approaches have included multi-
responsive polymers that lead to micelle disassembly to trigger release in cells.
14, 37, 45-48
 In many 
micellar systems, the preference for the encapsulation of the cargo over covalent conjugation, 
difficult self-assembly approaches, and sometimes limited control over loading and product 
yields make these strategies less attractive for translation. In order to overcome these limitations, 
we herein report the synthesis of a novel pH responsive, biodegradable polycarbonate, 
synthesized via an easily accessible ring opening polymerization method.  The introduction of 
the versatile norbornene moiety in the monomer structure affords the facile covalent attachment 
of multiple functionalities through a range of convenient routes. The self-assembled system was 
found to be highly biocompatible, as demonstrated by a viability > 95% in A549 (human lung 
cancer fibroblasts) and IMR-90 (human lung fibroblasts). Furthermore, the ability of the above 
cell lines to uptake such nanoparticles demonstrates their potential as drug delivery systems. 
 
EXPERIMENTAL SECTION 
Materials and Methods. All reagents used for the monomer synthesis, polymerization 
reactions and coupling reactions were purchased from Sigma-Aldrich. All reagents were used 
without any further purification, except for 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 
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benzyl alcohol which were dried over calcium hydride and distilled under vacuum before 
polymerization. BODIPYC10-SH,
49
 11-azidoundecanoic acid,
50
 and PEG550-SH,
51, 52
 were 
synthesized following previously published procedures. NMR spectra were recorded on a Bruker 
HD-300 and HD-400 spectrometer at 293 K unless otherwise stated. Chemical shifts are reported 
as δ in parts per million (ppm) and referenced to the chemical shift of the residual solvent 
resonances (CHCl3: 
1
H δ = 7.26 ppm, 13C δ = 77.16 ppm; DMSO: 6H δ = 2.50 ppm, 13C δ = 
39.52 ppm). Size exclusion chromatography (SEC) was used to determine the molecular mass 
and molecular mass distributions (dispersities, ÐM) of the synthesized polymers. SEC in 
chloroform was conducted on a system comprised of a Varian 390-LCMulti detector suite fitted 
with differential refractive index (DRI), light scattering (LS) and ultra-violet (UV) detectors, 
equipped with a guard column (Varian Polymer Laboratories PLGel 5 mM, 50 × 7.5 mm) and 
two mixed D columns (Varian Polymer Laboratories PLGel 5 mM, 300 × 7.5 mm). The mobile 
phase was chloroform with 5% triethylamine eluent at a flow rate of 1.0 mL min
-1
, and samples 
were calibrated against Varian Polymer laboratories Easi-Vials linear poly(styrene) standards 
(162-2.4 × 105 g mol
-1
) using Cirrus v3.3. Fluorescence microscopy images were obtained using 
fluorescence ORCM Hamamatsu camera, at ×20 magnification.  
 
Synthesis of 2-norbornene-5,5-bis(hydroxymethyl)-1,3-dioxane (NHD): Following 
previously reported procedures,
53, 54
 pentaerythritol (13.5 g, 99.2 mmol) was suspended in 100 
mL of deionised water and heated to 80 °C under stirring until all the solid had dissolved. The 
solution was cooled down to ambient temperature before the addition of conc. HCl (330 µL, 3.26 
mmol) with continual stirring for a further 15 min. 5-Norbornene-2-carboxaldehyde (10.0 g, 89.2 
mmol) was added drop-wise to the acidified solution over 20 min and allowed to stir for a further 
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2 h. The mono-functionalised product formed an orange precipitate which was collected via 
vacuum filtration before further purification by silica plug, ethyl acetate as the eluent, and re-
crystallization from hot toluene (30 mL) to yield white crystals (10.8 g, yield: 51 %). 
1
H NMR 
(400 MHz; DMSO-d6): δ 6.15 (dd, 1H, 
3
JH-H = 5.7, 3.0 Hz), 5.90 (dd, 1H, 
3
JH-H = 5.7, 3.0 Hz), 
4.52 (t, 1H, 
3
JH-H = 5.4 Hz), 4.40 (t, 1H, 
3
JH-H = 5.2 Hz), 3.76-3.66 (m, 3H), 3.54 (d, 2H, 
3
JH-H = 
5.2 Hz), 3.42 (m, 2H), 3.13 (d, 2H, 
3
JH-H = 5.2 Hz), 2.83 (s, 1H), 2.76 (s, 1H), 2.16 (ddd, 1H, 
3
JH-
H = 12.8, 8.5, 4.0 Hz), 1.72 (ddd, 1H, 
3
JH-H  = 12.8, 9.3, 3.8 Hz), 1.30-1.14 (m, 2H), 0.72 (ddd, 
1H, 
3
JH-H = 11.9, 4.1, 2.6 Hz). 
13
C NMR (101 MHz; DMSO-d6): δ 137.26 (CH), 132.58 (CH), 
105.41 (CH), 68.64 (CH2), 68.46 (CH2), 61.02 (CH2), 59.57 (CH2), 48.71 (CH2), 43.19 (CH), 
43.11 (CH), 41.62 (CH), 28.21 (CH2). 
 
Synthesis of 2-norbornene-5,5-bis(hydroxymethyl) trimethylene carbonate (NTC): In a 
dry 2-necked round bottom flask NHD (4.0 g, 16.7 mmol) was dissolved in 400 mL of THF and 
cooled to 0 °C using an ice-bath. Under a N2 blanket, ethyl chloroformate (4.78 mL, 49.9 mmol) 
was slowly added and the solution stirred for 30 min. Triethylamine (6.95 mL, 49.9 mmol) was 
added drop-wise over 45 min and the reaction was stirred for 3 h while being allowed to warm to 
ambient temperature. The resultant salt formed during the reaction was removed via vacuum 
filtration and was further rinsed with THF (20 mL). The filtrate and washings were combined 
and solvent was removed in vacuo to yield off-white crystals. The crude product was purified by 
re-crystallization from hot cyclohexane/THF (30 mL) to yield white crystals. NTC was dried 
over phosphorus pentoxide and stored in the glovebox (2.6 g, yield: 59 %). 
1
H NMR (400 MHz, 
CDCl3) δ 6.15 (dd, 
3
JH-H = 5.7, 3.0 Hz, 1H), 5.93 (dd, 
3
JH-H = 5.7, 2.8 Hz, 1H), 4.59 (app. s, 2H), 
4.05-3.83 (m, 3H), 3.96 (app. s, 2H), 3.57-3.52 (m, 2H), 2.93 (s, 1H), 2.83 (s, 1H), 2.27 (ddd, 
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3
JH-H = 12.8, 8.6, 3.9 Hz, 1H), 1.86 (ddd, 
3
JH-H = 12.8, 9.3, 3.8 Hz, 1H), 1.37-1.18 (m, 2H), 0.85 
(ddd, 
3
JH-H = 11.9, 4.1, 2.6 Hz, 1H). 
13
C NMR (300 MHz; CDCl3): δ 153.73 (C=O), 137.92 (CH), 
132.80 (CH), 128.65 (CH), 107.24 (CH), 68.67 (CH2), 67.17 (CH2), 49.39 (CH2), 43.85 (CH), 
42.22 (CH), 37.41 (CH), 28.51 (C). Mass spectrometry (ESI +ve); m/z = 267.12 (M
+
). Elemental 
analysis; anal. calcd for C14H18O5: C 63.15; H 6.18; N 0 %. Found: C 63.15, H 6.81, N 0.01 %. 
 
General procedure for the organocatalysed ROP of NTC: All polymerizations were carried 
out using standard glovebox and Schlenk-line techniques. The ROP of NTC using 1 mol% DBU 
was carried out in dry CDCl3 at ambient temperature using benzyl alcohol (BnOH) as the 
initiator. In a dry scintillation vial, NTC (66.5 mg, 2.5 × 10
-1
 mmol) was dissolved in 500 µL of 
CDCl3 before the addition of freshly prepared stock solutions of DBU (4 µL, 2.5 × 10
-3 
mmol, 1 
µL per 9 µL CDCl3 stock) and BnOH (dependant on target chain length). The polymerisation 
was stopped by precipitation into hexanes and the polymer recovered via a silica plug. The crude 
material was loaded onto the silica plug in CH2Cl2. The residual monomer was eluted using 
CH2Cl2 (Rf = 0.9) before a direct solvent switch to ethyl acetate was employed to elute the pure 
polymer (Rf = 0.9), with the DBU catalyst remaining on the silica (Rf = 0). DP20 homopolymer; 
1
H NMR (400 MHz; CDCl3): δ 7.36 (m, 5H), 6.15 (m, 20H), 5.93 (m, 20H), 5.15 (s, 2H) 4.54-
4.33 (m, 40H), 4.08-3.71 (m, 110H), 3.66-3.42 (m, 40H), 2.92 (s, 20H), 2.81 (s, 20H), 2.30 (m, 
20H), 1.81 (m, 20H), 1.44-1.15 (m, 40H), 0.82 (m, 20H). 
13
C NMR (101 MHz; CDCl3): δ 147.59 
(C=O), 137.51 (CH), 132.45 (CH), 105.96 (CH), 70.70 (CH2), 69.86 (CH2), 67.79 (CH2), 67.68 
(CH2), 48.70 (CH2), 43.07 (CH), 42.97 (CH), 41.61 (CH), 28.11 (CH2). Mn = 4.2 kg∙mol
-1
, ÐM = 
1.10 (RI detection, CHCl3 SEC). 
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Synthesis of PEG550 thiol: Poly(ethylene glycol) methyl ether (550 g mol
-1
), (10 g, 18 mmol) 
and 3-mercaptopropionic acid (3.82 g, 36 mmol) was dissolved in a mixture of benzene and 
toluene (1:1, 200 mL) and the mixture was heated to 80 °C. Two drops of H2SO4 were added and 
the solution was heated to reflux under Dean Stark conditions for 16 h. The solution was allowed 
to cool to room temperature and the solvent was evaporated. The residue was dissolved in 
CH2Cl2 (100 mL) and washed with saturated NaHCO3 solution (3 x 50 mL), brine (3 x 50 mL) 
and dried (MgSO4). Charcoal (ca. 0.1g) was added and the solution was filtered through Celite® 
545, evaporation of solvent yielded product as viscous yellow oil (Yield 9.65 g, 81%). 
1
H NMR 
(400 MHz; CDCl3): δ 4.18 (m, 2H), 3.73-3.38 (m, 52H), 3.28 (s, 3H), 2.71-2.58 (m, 4H), 1.62 (t, 
1H, 
3
JH-H = 16). 
1
H NMR spectroscopy indicated ca. 98% conversion of the hydroxyl group to 
mercaptopropionate group. Mn = 725 g∙mol
-1
, ÐM = 1.21 (RI detection, CHCl3 SEC). 
 
Functionalisation of Poly(NTC) (PNTC): Benzyl azide: In a dry vial fitted with a stirrer bar, 
PNTC (DP10) (50 mg, 2.11 × 10
-5
 mmol) was dissolved in 500 µL of 1,4-dioxane. Benzyl azide 
(28 µL, 2.11 × 10
-4 
mol) was added to the solution before being sealed and heated to 90 °C for 12 
h with stirring. The functionalised polymer was recovered by precipitation into cold methanol 
(15 mL) before being filtered and dried in vacuo. 
1
H NMR (400 MHz; CDCl3): δ 7.45-7.16 (m, 
62H), 5.13 (m, 2H), 4.91 (m, 10H), 4.69-2.99 (m, 223H), 2.82-2.51 (m, 17H), 2.39-0.66 (m, 
116H). Mn = 3.8 kg∙mol
-1
, ÐM = 1.14 (RI detection, CHCl3 SEC). 
Dodecanethiol: In a dry vial fitted with a stirrer bar, PNTC (DP10) (50 mg, 2.11 × 10
-5
 mol) 
was dissolved in 500 µL of CHCl3. Dodecanethiol (50 µL, 2.11 × 10
-4
 mol) and 2,2-dimethoxy-
2-phenylacetophenone photoinitiator (54 mg, 2.11 × 10
-4
 mol) were added to the solution before 
being sealed and UV irradiated for 30 min. The functionalised polymer was recovered by 
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precipitation into cold methanol methanol (15 mL) before being filtered and dried in vacuo. 
1
H 
NMR (400 MHz; CDCl3): δ 7.35 (m, 5H), 5.14 (s, 2H), 4.58-4.05 (m, 34H), 4.05-3.23 (m, 
100H), 2.86 (d, 22H), 2.66-1.05 (m, 194H), 0.97-0.67 (m, 28H). Mn = 4.6 kg∙mol
-1
, ÐM = 1.18 
(RI detection, CHCl3 SEC). 
PEG550 thiol: In a dry vial fitted with a stirrer bar, PNTC (DP20) (100 mg, 2.11 × 10
-5
 mol) 
was 
dissolved in 500 µL of THF. PEG550SH (232 mg, 4.22 × 10
-4 
mol) and 2,2-dimethoxy-2-
phenylacetophenone photoinitiator (106 mg, 4.22 × 10
-4
 mol) were added to the solution before 
being sealed and UV irradiated for 30 min. The functionalised polymer was recovered by 
precipitation into cold methanol methanol (15 mL) before being filtered and dried in vacuo. 
1
H 
NMR (400 MHz; DMSO-d6): δ 7.38 (s, 9H), 5.13 (s, 3H), 4.68-3.58 (m, 460H), 3.55-3.30 (m, 
1449H), 3.23 (s, 91H), 2.61 (m, 142H), 2.37-0.71 (m, 299H). Mn = 13.3 kg∙mol
-1
, ÐM = 1.10 (RI 
detection, CHCl3 SEC). 
Tetrazine: In a dry vial fitted with a stirrer bar, PNTC (DP10) (50 mg, 2.11 × 10
-5
 mol) was 
dissolved in 500 µL of 1,4-dioxane. 2,5-Dioxopyrrolidin-1-yl 6-(6-(pyrimidin-2-yl)-1,2,4,5-
tetrazin-3-yl)benzoate (76.6 mg, 2.11 × 10
-4
 mol) was added to the solution before being stirred 
at room temperature for 1 h. The functionalised polymer was recovered by precipitation into cold 
methanol methanol (15 mL) before being filtered and dried in vacuo. 
1
H NMR (400 MHz; 
CDCl3): δ 9.49-6.89 (m, 66H), 5.27 (s, 2H), 4.75-0.59 (m, 206H). Mn = 4.9 kg∙mol
-1
, ÐM = 1.2 
(RI detection, CHCl3 SEC). 
 
Synthesis of 4-(11-azido-undecanamide)-N-methyl phthalimide: 11-Azido undecanoic acid 
(258 mg, 1.14 × 10
-3
 mol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (220 mg, 1.14 × 
 10 
10
-3
 mol) were dissolved in CH2Cl2 (3 mL). 4-Amino-N-methylphthalimide (20 mg, 1.14 × 10
-4
 
mol) was then added and the reaction was stirred at 0 ˚C for 1 h, and for the following 24 h at rt. 
After this, the organic layer was diluted with CH2Cl2 (50 mL) and washed with 1 M HCl (3 × 50 
mL) and 0.1% NaHCO3 (3 × 50 mL). The organic layer was then dried with MgSO4 and the 
solvent removed in vacuo. The product was purified via flash chromatography (CH2Cl2/Acetone) 
and obtained as a pale yellow solid (yield = 63%). 
1
H NMR (300 MHz, CDCl3) δ 8.47 (s, 1H), 
8.07-8.03 (dd, 
3
JH-H = 3 Hz, 
3
JH-H = 9 Hz, 1H), 7.99 (d, 
3
JH-H = 3 Hz, 1H), 7.74 (d, 
4
JH-H = 9 Hz, 
1H), 3.22 (t, 
3
JH-H = 15 Hz, 2H), 3.13 (s, 3H), 2.43 (t, 
3
JH-H = 15 Hz, 2H), 1.71-1.67 (m, 2H), 
1.59-1.50 (m, 2H), 1.24 (m, 12H). 
13
C NMR (300 MHz; CDCl3): δ 171.88 (C=O), 168.30 (C=O), 
168.13 ((C=O), 143.64 (C), 133.90 (C), 126.93 (CH), 124.59 (C), 123.77 (CH), 114.03 (CH), 
51.60 (CH2), 37.96 (CH2), 29.51 (CH2), 29.43 (CH2), 29.33 (CH2), 29.22 (CH2), 28.95 (CH2), 
26.81 (CH2), 25.47 (CH3), 24.13. Mass spectrometry (ESI +ve); m/z = 315.3 (M
+
). Elemental 
analysis anal. calcd for C15H17N5O3: C 62.32; H 7.06; N 18.17. Found: C 61.99; H 7.03; N 17.71 
%. 
 
Synthesis of PNTC-g-BODIPY-g-PEG conjugate: In a dry vial fitted with a stirrer bar, 
PNTC (DP20) (50 mg, 1.09 × 10
-5
 mol) was dissolved in 500 µL of CHCl3. BODIPYC10-SH (10 
mg, 2.4 × 10
-5
 mol) and 2,2-dimethoxy-2-phenylacetophenone (6 mg, 2.4 × 10
-5
 mol) were added 
to the solution before being sealed and UV irradiated for 30 min. The functionalised polymer 
was recovered by precipitation into cold diethyl ether methanol (15 mL) before being filtered and 
dried in vacuo. 
1
H NMR (400 MHz; CDCl3): δ 7.37 (m, 5H), 6.15 (m, 20H), 6.05 (s, 1H), 5.93 
(m, 20H), 5.16 (m, 2H), 4.42 (m, 40H), 3.97-3.81 (m, 89H), 3.57 (m, 22H), 3.31 (m, 2H), 2.93-
2.81 (m, 40H), 2.51-2.41 (m, 8H), 2.30 (m, 23H), 1.87-1.80 (m, 28H), 1.58 (m, 11H), 1.38-1.21 
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(m, 20H), 0.97 (s), 0.95 (s, 3H with δ 0.97), 0.90-0.81 (m, 20H). Mn = 4.4 kg∙mol
-1
, ÐM =1.17 
(RI detection, CHCl3 SEC), Mn = 4.3 kg∙mol
-1
, ÐM =1.17 (UV detection, 475 nm, CHCl3 SEC). 
PNTC-g-BODIPY (53 mg, 1.2 × 10
-5
 mol) was then re-dissolved in 500 µL of CHCl3. PEG550-
SH (145 mg, 2.2 × 10
-4
 mol) and 2,2-dimethoxy-2-phenylacetophenone (56 mg, 2.2 × 10
-4
 mol) 
were added to the solution before being sealed and UV irradiated for 30 min. The functionalised 
polymer was recovered by precipitation into cold diethyl ether methanol (15 mL) before being 
filtered and dried in vacuo. 
1
H NMR (400 MHz; CDCl3): δ 7.35 (m, 5H), 6.03 (s, 1H), 5.13 (m, 
2H), 4.38-4.23 (m, 90H), 3.92 (m, 72H), 3.62 (m, 810H), 3.48-3.42 (m, 118H), 3.35 (m, 50H), 
2.76 (m, 24H), 2.61 (m, 27H), 2.48-2.39 (m, 9H), 2.28-2.19 (m, 20H), 2.00 (m, 20H), 1.64 (m, 
30H), 1.26 (m, 10H), 0.90-0.81 (m, 16H). Mn = 17.3 kg∙mol
-1
, ÐM = 1.35 (RI detection, CHCl3 
SEC), Mn = 16.2 kg∙mol
-1
, ÐM = 1.35 (UV detection, 475 nm, CHCl3 SEC). 
 
Synthesis of PNTC-g-Phthalimide-g-PEG conjugate: In a dry vial fitted with a stirrer bar, 
PNTC (DP20) (50 mg, 1.09 × 10
-5
 mol) was dissolved in 500 µL of CHCl3. Phthalimide-azide 
(10.4 mg, 3.3 × 10
-5
 mol) was added and the solution was stirred overnight at 90 °C. The 
functionalised polymer was recovered by precipitation into cold methanol (15 mL) before being 
filtered and dried in vacuo. 
1
H NMR (500 MHz; CDCl3): δ 8.03-7.37 (m, 26H), 6.15-5.91 (m, 
35H), 4.42 (m, 45H), 3.93 (m, 111H), 3.13-1.98 (m, 120H), 1.69-1.32 (m, 94H). Mn = 4.4 
kg∙mol-1, ÐM = 1.35 (RI detection, CHCl3 SEC); Mn = 3.9 kg∙mol
-1
, ÐM = 1.41 (UV detection, 
375 nm, CHCl3 SEC). PNTC-g-Phthalimide (70 mg, 1.61 × 10
-5
 mol) was then re-dissolved in 
500 µL of CHCl3. PEG550-SH (79.3 mg, 1.8 × 10
-5
 mol) and 2,2-dimethoxy-2-
phenylacetophenone (31 mg, 1.2 × 10
-4
 mol) were added to the solution before being sealed and 
UV irradiated for 30 min. The functionalised polymer was recovered by precipitation into cold 
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methanol (15 mL) before being filtered and dried in vacuo. 
1
H NMR (500 MHz; CDCl3): δ 8.20-
7.36 (m, 20H), 4.41 (m, 45H), 4.24 (m, 39H), 3.95 (m, 76H), 3.64 (m, 415H), 3.36 (s, 25H), 
3.12-2.28 (m, 90H), 2.27-1.90 (m, 55H), 1.82-1.60 (m, 44H), 1.24 (m, 51H), 0.83 (m, 14H). Mn 
= 17.6 kg∙mol-1, ÐM = 1.29 (RI detection, CHCl3 SEC); Mn = 15.9 kg∙mol
-1
, ÐM = 1.48 (UV 
detection, 375 nm, CHCl3 SEC). 
 
Cleavage of acetals: In a dry vial fitted with a stirrer bar, PNTC (DP10) (50 mg, 2.11 × 10
-5
 
mol) was suspended in 1 mL of ethanol. 0.01 M HCl (10 µL) was added to the solution before 
being sealed and stirred for 16 h. The cleaved polymer was recovered by precipitation into 
hexanes methanol (15 mL) before being filtered and dried in vacuo. Mn = 4.2 kg∙mol
-1
, ÐM = 
1.32 (RI detection, CHCl3 SEC). 
 
Self-assembly and multi-angle light scattering analysis: PNTC-g-PEG550 polymers were 
self-assembled by solvent switch method. A solution of polymer (5 mg) was dissolved in THF (1 
mL) at a concentration of 5 mg mL
-1
 and stirred overnight. 9 mL of DI H2O was then added 
slowly (0.6 mL h
-1
). The micelles’ solution was then dialysed for 2 days to remove the THF, with 
frequent changes of water (MWCO = 3.5 kDa). The micelles were then freeze dried, resuspended 
in water at a concentration of 1 mg mL
-1
, and stirred at room temperature overnight before being 
filtered (0.45 µm filters) and analysed via DLS and SLS. 
 
Transmission electron microscopy (TEM) analysis: Samples for TEM analysis were 
prepared by drop casting 7 µL from a solution of micelles dialysed in water (0.5 mg mL
-1
) onto a 
carbon/formvar-coated copper grid placed on filter paper. Samples were stained with a 1% 
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uranyl acetate solution to facilitate imaging of the thin organic structures unless specified. 
Samples were also prepared on graphene oxide support films
55
 to negate the necessity for 
staining. Imaging was performed on a Jeol 2000 transmission electron microscope operating at 
120 kV. 
 
Viability studies on A549 and IMR-90 cell lines: A549 and IMR-90 cells were cultured in 
F12K and DMEM, respectively, with addition of 10% FBS and 100U mL
-1
 pen/strep. Cells were 
seeded on 12 well plates at 2000 cells cm
-2
 and left adhere and proliferate for 72 h. The medium 
was then replaced with PNTC-g-PEG550 in a concentration range from 0 to 2 mg mL
-1
. Briefly, a 
solution of micelles in water (50 mg mL
-1
) was sterile filtered through a 0.22 µm filter. This 
solution was then diluted with cell culture medium (with the addition of 10% FBS and 100U mL
-
1
 pen/strep) to a final concentration of 10 mg mL
-1
. This stock solution was then used to prepare 
the dilutions directly on the well plates containing cells. After 72 h the solution was removed, 
cells were washed with PBS (1 mL × 3) and incubated with 10% PrestoBlue viability assay 
following the supplier instructions. The fluorescence intensity (FI) was detected in a BioTek 
Plate Reader (λex = 530 nm, λem = 590 nm). Cell data are reported as viability % in comparison 
with control sample. Experiments were performed in triplicate.  
 
Internalization studies on A549 and IMR-90 with PNTC-g-BODIPY-g-PEG: Cells were 
seeded on 12 well plates at 2000 cells cm
-2
 and left to adhere for 72 h. The medium was then 
replaced with 0.1 mg mL
-1
 PNTC-g-BODIPY-g-PEG550. At 2, 4, and 6 h time points, the 
nanoparticle solution was removed and cells washed with PBS (1 mL × 3). Cells were fixed 
using 4% paraformaldehyde, and cell membranes were permeabilized using 0.5% Triton X-100 
 14 
in cytoskeleton stabilization (CS) buffer (0.1 M PIPES, 1 mM EGTA, and 4% (w/v) 8000 MW 
polyethylene glycol) at 37 °C on a dry block for 10 min, rinsed thrice for 5 min each in CS 
buffer, and incubated in 0.1% sodium borohydride in PBS at ambient temperature for 10 min. 
Samples were then blocked in 5% donkey serum for 20 min at 37 °C, washed with 1% donkey 
serum and incubated for 1 h with rhodamine phalloidin (1:200), followed by DAPI (1:10) for 10 
min to stain the cell nuclei. Cells were imaged using fluorescence DAPI (λex/λem = 350/470 nm), 
FITC (λex/λem = 490/525 nm) and TRITC (λex/λem = 556/563 nm) channels. At least 10 pictures 
from each glass slide (19 mm in diameter) were taken. Experiments were performed in triplicate. 
 
RESULTS AND DISCUSSION  
9-Norbornene-2,4,8,10-tetraoxaspiro[5,5]undecan-3-one (NTC) was synthesized through the 
acid-catalyzed acetal formation of pentaerythritol with 5-norbornene-2-carboxyaldehyde and the 
subsequent ring closure reaction with ethyl chloroformate, following previously reported 
procedures for the preparation of spirocyclic carbonate monomers (Scheme 1, Figure S1).
53, 54, 56, 
57
 The monomer was obtained after a two-step synthesis in 60% yield and purified using 
filtration and recrystallization. The organocatalyzed ring opening polymerization (ROP) of NTC 
was initiated from benzyl alcohol in CHCl3 at ambient temperature, using 5 mol% 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) as a catalyst (Scheme 1, Figures S2-S3). This procedure 
can be undertaken in air without extensive drying of monomers and solvents, thus presenting a 
simple and scalable method for polymer preparation.
58
 The polymerization exhibited a first order 
kinetic and the number-average molecular mass, Mn, displayed a linear increase with increasing 
monomer conversion (Figures 1 and S4, and Table S1). The resultant polymers exhibited 
predictable molecular mass and narrow molecular mass distributions (ÐM = 1.09-1.20) at a range 
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of degrees of polymerization (DP) (10, 20, 50, 100, 250), which indicate the controlled nature of 
this process with minimal adverse side reactions (i.e. transesterification) occurring during ROP 
(Figure 1). Importantly, 
1
H NMR spectroscopy and MALDI-ToF-MS confirmed complete 
retention of the norbornene functionality (Figures S2 and S3). 
Scheme 1. Synthesis of NTC from pentaerythritol and NTC ROP initiated from benzyl 
alcohol. a) 5-norbornene-2-carboxyaldehyde, HCl, deionised H2O, 80 ˚C to 25 ˚C; b) Ethyl 
chloroformate, Et3N, THF, 0 ˚C to 25 ˚C; c) Benzyl alcohol, 5 mol% DBU, CHCl3, 25 ˚C. 
 
 
Figure 1. a) Size exclusion chromatograms (SEC) of NTC polymerizations with increasing 
[M]0/[I]; b) Plot of Mn (obtained via SEC) against monomer conversion (obtained via 
1
H NMR 
spectroscopy) throughout the ROP of NTC (5 mol% DBU, CHCl3, 25 ˚C), where dotted line 
represents linear fit to the data. 
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Norbornene moieties are versatile and able to participate in a number of conjugation reactions, 
including halide addition, cycloaddition, thiol-ene reactions, and (hetero) Diels-Alder 
reactions.
59-62
 As such, in order to highlight its versatility, poly-NTC (PNTC) (DP 10) was 
modified with benzyl azide via a 1,3-dipolar cycloaddition, with 2,5-dioxopyrrolidin-1-yl 6-(6-
(pyrimidin-2-yl)-1,2,4,5-te trazin-3-yl) benzoate via an inverse electron demand Diels-Alder 
(DAinv) reaction, and with 1-dodecanethiol via a photoinduced radical thiol-ene addition (Figure 
2a). Analysis by FT-IR spectroscopy (Figure 2b) and 
1
H NMR spectroscopy (Figure S5) 
confirmed quantitative functionalization, with complete disappearance of the alkene norbornene 
peaks. Furthermore, SEC analysis revealed that the number average molecular mass of each 
modified polymer increased with no significant change in dispersity (ÐM = 1.14-1.12) (Figure 
2c). This is indicative of the controlled nature of the post-polymerization modifications, with 
minimal adverse side reactions i.e. backbone degradation or chain-chain coupling, and 
demonstrates the versatility of this approach to enable the conjugation of additives through 
routes that are the most synthetically accessible. 
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Figure 2. Post-polymerization functionalization of PNTC. a) Scheme of post polymerization 
functionalization reactions via photoinduced radical thiol-ene addition, 1,3-dipolar cycloaddition, 
and inverse electron demand Diels-Alder (DAinv) reaction; b) FT-IR spectra of PNTC before 
(solid black line) and after (dashed red line) functionalization with dodecanethiol, showing the 
disappearance of the norbornene alkene peak at 3057 cm
-1
; c) SEC of PNTC before (dashed line) 
and after (solid lines) functionalization with benzyl azide (blue), dodecanethiol (red) and 
tetrazine (green). 
Beyond the versatility in the conjugation approach, a second advantage is represented by the 
pH responsive acetal bond.
36, 37
 To demonstrate the cleavability of this bond, modified PNTCs 
were subjected to acidic conditions (pH 5) in order to determine the capability of these functional 
polycarbonates to release the grafted fragments. As expected, SEC analysis after 16 h (Figure 3 
and Table S2) revealed a significant decrease in molar mass, with an increase in dispersity (ÐM = 
1.23-1.27). Interestingly, however, it was noted that each of the cleaved polymers exhibited 
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comparable number average molar mass (Mn = 4.1-4.7 kg mol
-1
), which is indicative of complete 
cleavage.  
 
Figure 3. (a) Scheme and (b) and size exclusion chromatograms of PNTC (solid black line) 
functionalized with benzyl azide (blue), tetrazine (green) and dodecanethiol (red), before (dashed 
lines) and after (solid lines) cleavage with 0.01 M HCl at pH 5.0 for 16 h.  
In order to efficiently serve as a delivery carrier, the polymer conjugate should be able to self-
assemble into nanostructures that isolate the cargo from the external environment and deliver it 
inside a cell. For this reason, an amphiphilic copolymer was synthesized by the introduction of 
poly(ethylene glycol) (PEG) to the polymer backbone via the norbornene functionality. 3-
Mercaptopropionate-functionalized PEG methyl ether (Mn = 550 g mol
-1
) (PEG550-SH) was 
grafted to PNTC (DP20) using a radical thiol-ene addition. As with the 1-dodecanethiol addition, 
1
H NMR spectroscopy and SEC analysis show that full grafting was achieved (Figure S6 and 
S7). The amphiphilic graft copolymer PNTC-g-PEG550 subsequently self-assembled via a solvent 
exchange method in water to obtain micelles ~12 nm in diameter, as confirmed by dynamic light 
scattering (DLS) and transmission electron microscopy (TEM) analyses (Figure S8). Particle 
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disassembly at pH 5.0 was evaluated using static light scattering (SLS). After 16 h of incubation 
at acidic pH, the micelles’ molecular weight decreases, and the calculated aggregation number 
(Nagg.) switches from 27 polymer chains per micelle to 3, indicating disassembly of the 
nanostructures (Table S3). The biocompatibility of the resultant micelles was assessed by 
incubating A549 and IMR-90 cells with an increasing concentration of nanoparticles, from 0 to 2 
mg mL
-1
 up to 72 h. Viability was found to be higher than 95% for both cell lines used (Figure 
S9), which suggests that this graft-copolymer-based nanoparticle system has a great potential for 
drug delivery.  
In order to investigate the internalization of the nanoparticles into the cells, fluorescent dyes 
were conjugated to PNTC via either thiol-ene addition, with BODIPYC10-SH, or 1,3-dipolar 
cycloaddition with 4-(11-azido-undecanamide)-N-methyl phthalimide (Figures S10-S13). As 
expected, loading was predictable based on the amount of dye added (10% for BODIPYC10-SH 
and 25% for 4-(11-azido-undecanamide)-N-methyl phthalimide)), demonstrating the high 
efficiency of the post-polymerization reactions. In both cases, fluorescent nanoparticles of 15 nm 
in diameter were obtained upon grafting of PEG550-SH to the remaining norbornene units, as 
characterized by DLS and TEM (Figures 4 and S14) which showed that the addition of these 
hydrophobic components did not have a significant effect on the size of the nanoparticles.  
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Figure 4. (a) DLS (173˚) distribution by intensity, volume and number, with correlation 
function (inset) showing a single particles distribution. The peak at 370 nm shown in the 
intensity distribution is likely to be an artifact due to the absorbance and fluorescence of the 
nanoparticles. (b) TEM micrograph of PNTC-g-BODIPY-g-PEG550 nanoparticles stained with 
1% uranyl acetate. Scale bar = 500 nm. Particle size was measured as 15 nm by DLS (PD = 0.2), 
and 14 ± 0.3 nm by TEM. 
 
PNTC-g-BODIPY-g-PEG550 nanoparticles were then incubated with A549 and IMR-90 cell 
lines. Nanoparticle internalization was investigated using a polymer concentration of 0.1 mg mL
-
1
, and time points were taken at 2, 4, and 6 h after incubation, at which point nanoparticles 
appear to homogeneously distribute within the cytosolic compartment for both cell types 
(Figures 5 and S15). This suggests that our novel polycarbonate can be used as a drug delivery 
vehicle, being highly biocompatible and able to enter the cell compartment.  
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Figure 5. A549 (a), and IMR-90 (b) cell lines incubated for 6 h with 0.1 mg mL
-1
 of PNTC-g-
BODIPY-g-PEG550 nanoparticles. Nanoparticles fluoresce in green, cells cytoskeletons are 
stained with rhodamine phalloidin (red) and nuclei are stained with DAPI (blue). 
 
 
CONCLUSIONS 
Herein we report the monomer synthesis and polymerization of a novel, functional 
polycarbonate scaffold that contains both a versatile norbornene group for post-polymerization 
modification and a pH responsive acetal group for triggered release. Importantly, the scaffolds 
can be realized by simple and scalable chemistry.  Taking advantage of these properties, the 
polycarbonate was conjugated to thiol functionalized BODIPYC10, azide functionalized N-
methyl phthalimide derivative, and PEG and self-assembled into polymeric micelles to explore 
their ability to be internalized into mammalian cells. Furthermore, the ability to precisely control 
the loading of small molecules on the polymer backbone offers great advantage for drug delivery 
purposes. Our polymer system was found to be highly biocompatible, with a viability higher than 
95% after 72 h of incubation, and was internalized by the two human cell lines considered in this 
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study (A549 and IMR-90). The simplicity of this approach, in combination with the 
biodegradable and biocompatible polymers applied opens the possibility to further explore these 
polymeric systems for a range of nanomedicine therapies in vivo.  
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